PenumbraMEX:PEN 89 FCF Yield % is 1.71 as of Jun. 27, 2026, which is 17000% above its 10-year median of 0.01. GuruFocus rates MEX:PEN with a GF Score™ of 89/100 and a GF Value™ of MXN4,981.98. The stock has 1 warning sign investors should review. Among 855 Medical Devices & Instruments companies, Penumbra ranks better than 62.92% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Penumbra's Trailing 12-Month Free Cash Flow is MXN3,867 Mil, and Market Cap is MXN218,164 Mil. Therefore, Penumbra's FCF Yield % for today is 1.71%.
The historical rank and industry rank for Penumbra's FCF Yield % or its related term are showing as below:
MEX:PEN'
s FCF Yield % Range Over the Past 10 Years
Min: -1.47 Med: 0.01 Max: 1.79
Current: 1.71
During the past 13 years, the highest FCF Yield % of Penumbra was 1.79%. The lowest was -1.47%. And the median was 0.01%.
MEX:PEN's FCF Yield % is ranked better than 62.92% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs MEX:PEN: 1.71
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Penumbra FCF Yield % Related Terms
Penumbra FCF Yield % Historical Data
* Premium members only.
The historical data trend for Penumbra's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:PEN vs GMED, PODD, MASI: FCF Yield % Comparison
For the Medical Devices subindustry, Penumbra's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Penumbra FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Penumbra's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Penumbra (MEX:PEN) has a FCF Yield % of 1.71 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Penumbra and its competitors. This is 17000% above median its historical median of 0.01. According to the industry distribution chart, Penumbra ranks #317 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 37.1%.
Is Penumbra's FCF Yield % too high?
Penumbra's current FCF Yield % of 1.71 is 17000% above median its 10-year median of 0.01. Based on the distribution chart, Penumbra ranks #317 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Penumbra has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Penumbra's FCF Yield % compare to GMED and PODD?
According to the Medical Devices & Instruments industry distribution chart, Penumbra ranks #317 out of 855 companies for FCF Yield %. This puts Penumbra in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Penumbra and its competitors. Penumbra's current FCF Yield % is 1.71, which is 17000% above median its own 10-year median of 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Penumbra stock overvalued right now?
Penumbra (MEX:PEN) has a current FCF Yield % of 1.71. The stock's GF Value™ is MXN4,981.98, compared to a current price of MXN4,775.70 — trading 4.1% below its estimated fair value. The current FCF Yield % is 1.71, which is 17000% above median its 10-year median of 0.01. Penumbra's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Penumbra (MEX:PEN), the current FCF Yield % is 1.71 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Penumbra (MEX:PEN) Overvalued in 2026?
Based on GuruFocus' analysis, Penumbra stock appears to be undervalued.
The current stock price of MXN4,775.70 is trading 4.1% below its estimated GF Value™ of MXN4,981.98.
Key valuation signals for MEX:PEN:
FCF Yield %: 1.71 (17000% above median its 10-year median of 0.01)
GF Value™: MXN4,981.98 vs. price of MXN4,775.70 (4.1% below fair value)
No single metric tells the full story. See the MEX:PEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
89GF Score
Get the complete analysis for MEX:PEN
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PEN has been successfully added to your 
